首页>
外国专利>
SRC KINASE INHIBITION AS TREATMENT FOR LYMPANGIOLEIOMYOMATOSIS AND TUBEROUS SCLEROSIS
SRC KINASE INHIBITION AS TREATMENT FOR LYMPANGIOLEIOMYOMATOSIS AND TUBEROUS SCLEROSIS
展开▼
机译:抑制SRC激酶治疗淋巴结血肌病和顽固性硬化症
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided herein are methods of treating lymphangioleiomyomatosis or tuberous sclerosis complex using one or more Src inhibitors. The Src inhibitor may be saracatinib, in some cases. In particular aspects, an individual being treated with methods of the disclosure are also provided one or more inhibitors of mTOR.
展开▼